Rang	Name	Position
1	Dr. Jeffrey Alan Graves Ph.D.	President, CEO & Director
2	Dr. Charles W. Hull	Co-Founder, Executive VP, CTO of Regenerative Medicine & Director Emeritus
3	Ms. Phyllis B. Nordstrom	Executive VP, CFO & Chief Administrative Officer
4	Dr. Joseph Zuiker	Executive Vice President of Engineering & Operations
5	Mr. Reji Puthenveetil	Executive VP of Additive Solutions & Chief Commercial Officer
6	Mr. Andrew William-Banasick Wright J.D.	Senior VP of General Counsel & Corporate Secretary

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	State Street Corp	6,91%	38,12 Mio. USD
2	BlackRock Inc	6,53%	36,00 Mio. USD
3	AIGH Capital Management, LLC	4,38%	24,14 Mio. USD
4	Two Sigma Investments LLC	3,95%	21,79 Mio. USD
5	Vanguard Capital Management, LLC	3,50%	19,31 Mio. USD
6	D. E. Shaw & Co LP	2,56%	14,14 Mio. USD
7	Geode Capital Management, LLC	2,04%	11,26 Mio. USD
8	Medina Singh Partners, LLC	1,97%	10,89 Mio. USD
9	Marshall Wace Asset Management Ltd	1,92%	10,58 Mio. USD
10	Silverberg Bernstein Capital Management LLC	1,68%	9,26 Mio. USD
11	Dimensional Fund Advisors, Inc.	1,38%	7,61 Mio. USD
12	UBS Group AG	1,25%	6,92 Mio. USD
13	Nuveen, LLC	1,20%	6,62 Mio. USD
14	Archon Capital Management LLC	1,05%	5,80 Mio. USD
15	The Goldman Sachs Group Inc	0,90%	4,97 Mio. USD
16	Clark Estates Inc	0,85%	4,71 Mio. USD
17	Jane Street Group LLC	0,76%	4,19 Mio. USD
18	Tudor Investment Corp Et AL	0,75%	4,15 Mio. USD
19	Panagora Asset Management Inc	0,71%	3,90 Mio. USD
20	Charles Schwab Investment Management Inc	0,70%	3,86 Mio. USD